Health-related quality of life in patients with unresectable hepatocellular carcinoma treated with SIRT and nivolumab: a sub-analysis of the NASIR-HCC trial.
De la Torre-Aláez M, Matilla A, Varela M, Iñarrairaegui M, Reig M, Lledó JL, Arenas JI, Lorente S, Testillano M, Márquez L, Iserte G, Argemí J, Gómez-Martin C, Rodríguez-Fraile M, Bilbao JI, Pollock RF, Pöhlmann J, Agirrezabal I, Sangro B J Patient Rep Outcomes. 2025 Apr 8;9(1):39. doi: 10.1186/s41687-025-00873-6. PMID: 40198533 Free [...]


